ITFI20050206A1 - Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione - Google Patents

Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione

Info

Publication number
ITFI20050206A1
ITFI20050206A1 IT000206A ITFI20050206A ITFI20050206A1 IT FI20050206 A1 ITFI20050206 A1 IT FI20050206A1 IT 000206 A IT000206 A IT 000206A IT FI20050206 A ITFI20050206 A IT FI20050206A IT FI20050206 A1 ITFI20050206 A1 IT FI20050206A1
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
preparation
controlled release
venlafaxine
chloridrate
Prior art date
Application number
IT000206A
Other languages
English (en)
Inventor
Tiziano Alighieri
Serozh Avanessian
Roberto Valducci
Original Assignee
Valpharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valpharma Sa filed Critical Valpharma Sa
Priority to IT000206A priority Critical patent/ITFI20050206A1/it
Priority to BRPI0616276-2A priority patent/BRPI0616276A2/pt
Priority to US11/992,285 priority patent/US20090263471A1/en
Priority to RU2008117111/15A priority patent/RU2423105C2/ru
Priority to JP2008532796A priority patent/JP2009510027A/ja
Priority to AT06819063T priority patent/ATE521339T1/de
Priority to NZ567735A priority patent/NZ567735A/en
Priority to CA002622822A priority patent/CA2622822A1/en
Priority to PCT/EP2006/066906 priority patent/WO2007039569A2/en
Priority to EP06819063A priority patent/EP1928424B1/en
Priority to KR1020087006551A priority patent/KR20080047557A/ko
Priority to AU2006298693A priority patent/AU2006298693A1/en
Priority to ES06819063T priority patent/ES2373164T3/es
Priority to CNA2006800325469A priority patent/CN101257893A/zh
Publication of ITFI20050206A1 publication Critical patent/ITFI20050206A1/it
Priority to IL190305A priority patent/IL190305A0/en
Priority to NO20081733A priority patent/NO20081733L/no
Priority to ZA200803502A priority patent/ZA200803502B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
IT000206A 2005-09-30 2005-09-30 Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione ITFI20050206A1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT000206A ITFI20050206A1 (it) 2005-09-30 2005-09-30 Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione
CA002622822A CA2622822A1 (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
KR1020087006551A KR20080047557A (ko) 2005-09-30 2006-09-29 방출 조절형 벤라팍신 히드로클로라이드계 약제학적 조성물및 그의 제조 방법
RU2008117111/15A RU2423105C2 (ru) 2005-09-30 2006-09-29 Фармацевтическая композиция с контролируемым высвобождением венлафаксина гидрохлорида и способ ее получения
JP2008532796A JP2009510027A (ja) 2005-09-30 2006-09-29 ベンラファキシン塩酸塩の制御放出性の医薬組成物、及びその調製方法
AT06819063T ATE521339T1 (de) 2005-09-30 2006-09-29 Pharmazeutische zusammensetzung aus venlafaxin- hydrochlorid mit kontrollierter freisetzung und herstellungsverfahren dafür
NZ567735A NZ567735A (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
BRPI0616276-2A BRPI0616276A2 (pt) 2005-09-30 2006-09-29 composiÇço farmacÊutica de liberaÇço controlada de cloridrato de venlafaxina e processo de preparaÇço da mesma
PCT/EP2006/066906 WO2007039569A2 (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
EP06819063A EP1928424B1 (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
US11/992,285 US20090263471A1 (en) 2005-09-30 2006-09-29 Controlled Release Pharmaceutical Composition of Venlafaxine Hydrochloride, and Process for Preparation Thereof
AU2006298693A AU2006298693A1 (en) 2005-09-30 2006-09-29 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
ES06819063T ES2373164T3 (es) 2005-09-30 2006-09-29 Composición farmacéutica de liberación controlada de clorhidrato de venlafaxina, y procedimiento para la preparación de la misma.
CNA2006800325469A CN101257893A (zh) 2005-09-30 2006-09-29 文拉法辛盐酸盐的控释药物组合物及其制备方法
IL190305A IL190305A0 (en) 2005-09-30 2008-03-19 Controlled release, pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
NO20081733A NO20081733L (no) 2005-09-30 2008-04-07 Kontrollert frigjorende farmasoytisk sammensetning av venlafaksinhydroklorid og fremgangsmate for dens fremstilling
ZA200803502A ZA200803502B (en) 2005-09-30 2008-04-21 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000206A ITFI20050206A1 (it) 2005-09-30 2005-09-30 Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione

Publications (1)

Publication Number Publication Date
ITFI20050206A1 true ITFI20050206A1 (it) 2007-04-01

Family

ID=36215990

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000206A ITFI20050206A1 (it) 2005-09-30 2005-09-30 Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione

Country Status (17)

Country Link
US (1) US20090263471A1 (it)
EP (1) EP1928424B1 (it)
JP (1) JP2009510027A (it)
KR (1) KR20080047557A (it)
CN (1) CN101257893A (it)
AT (1) ATE521339T1 (it)
AU (1) AU2006298693A1 (it)
BR (1) BRPI0616276A2 (it)
CA (1) CA2622822A1 (it)
ES (1) ES2373164T3 (it)
IL (1) IL190305A0 (it)
IT (1) ITFI20050206A1 (it)
NO (1) NO20081733L (it)
NZ (1) NZ567735A (it)
RU (1) RU2423105C2 (it)
WO (1) WO2007039569A2 (it)
ZA (1) ZA200803502B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2640094C (en) 2006-02-03 2015-04-14 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
PT3357496T (pt) 2006-06-21 2020-05-12 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
CN101668532B (zh) 2007-04-25 2014-08-20 赛特克罗公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途
EP2148683A4 (en) 2007-04-25 2012-09-12 Proventiv Therapeutics Llc METHOD FOR THE SAFE AND EFFECTIVE TREATMENT AND PREVENTION OF SECONDARY HYPERPARATHYREOSIS IN CHRONIC KIDNEY DISEASE
JP5501956B2 (ja) 2007-04-25 2014-05-28 シトクロマ インコーポレイテッド ビタミンｄ化合物およびワックス状担体を含有する制御放出性経口組成物
CA2714996C (en) 2008-04-02 2020-04-07 Cytochroma Inc. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
CN102085197B (zh) * 2010-12-14 2013-08-14 北京万生药业有限责任公司 一种文拉法辛缓释制剂及其制备方法
CN103181916A (zh) * 2011-12-30 2013-07-03 昆明积大制药股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2015298858A1 (en) 2014-08-07 2017-03-02 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin D
IL290855B1 (en) 2016-03-28 2024-02-01 Eirgen Pharma Ltd Treatment methods using vitamin D

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
CA2507685A1 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci

Also Published As

Publication number Publication date
WO2007039569A2 (en) 2007-04-12
EP1928424B1 (en) 2011-08-24
ES2373164T3 (es) 2012-02-01
KR20080047557A (ko) 2008-05-29
US20090263471A1 (en) 2009-10-22
NZ567735A (en) 2011-03-31
BRPI0616276A2 (pt) 2011-06-14
RU2423105C2 (ru) 2011-07-10
AU2006298693A1 (en) 2007-04-12
CA2622822A1 (en) 2007-04-12
JP2009510027A (ja) 2009-03-12
ATE521339T1 (de) 2011-09-15
IL190305A0 (en) 2009-09-22
WO2007039569A3 (en) 2007-07-26
RU2008117111A (ru) 2009-11-10
EP1928424A2 (en) 2008-06-11
CN101257893A (zh) 2008-09-03
NO20081733L (no) 2008-04-07
ZA200803502B (en) 2009-01-28

Similar Documents

Publication Publication Date Title
ITFI20050206A1 (it) Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione
AR116052A2 (es) Forma cristalina de clorhidrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol
ATE418967T2 (de) Matrix für die modifizierte freigabe von aktiven substanzen
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
ECSP056229A (es) Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres
AR049083A1 (es) Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
BRPI0409652A (pt) tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete
HUP0500540A2 (hu) Vanlafaxin-hidrokloridot tartalmazó, nyújtott hatóanyag-leadású készítmények
ECSP077243A (es) Formulación de pelet de liberación extendida que contiene pramipexol o una de sus sales farmacéuticamente aceptable, un método para su fabricación y su uso
CL2008000058A1 (es) Formulacion que comprende un anticuerpo anti-il13, un criprotector, y una solucion amortiguadora; composicion farmaceutica que la comprende; metodo para tratar un trastorno relacionado con il13; y formas farmaceuticas que la comprenden.
BRPI0815766A2 (pt) Composição pesticida, e, método para potencializar a eficácia de um ingrediente ativo pesticida.
CL2004000416A1 (es) Compuestos heterociclicos nitrogenados; composicion farmaceutica; y uso del compuesto para tratar o prevenir una condicion mediada por p38, que consiste en una enfermedad inflamatoria, autoinmune, virosica o neurodegenerativa.
WO2005097064A3 (en) Taste-masked drugs in rupturing multiparticulates
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
TW200643064A (en) Transparent film and method for manufacturing the same, polarized plate and image display device
BRPI0914371A2 (pt) "composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo, e produto de combinação"
DE122012000026I1 (de) Wirkstoffhaltige feste formkorper zur auserlichen anwendung gegen parasiten an tieren.
BRPI0620345A2 (pt) composto, composição farmacêutica, uso de um composto, e, métodod para o tratamento de uma doença
EP1693062A3 (en) Androgen receptor-dependent gene expression control
NO20074676L (no) Krystallinske former av (1 RS, 3RS, 6RS)-6-dimetylaminometyl-1-(3-metoksy-fenyl)cykloheksan-1,3-diol hydroklorid
BRPI0820210A2 (pt) composto, composição farmacêutica, uso de um composto, e, método de tratamento terapêutico de um mamífero.
CL2007003172A1 (es) Metodo para tratar a un mamifero que sufre de un tumor, que comprende administrar un compuesto n-{5-[(2r)-2-metoxi-2-feniletanoil]-1,4,5,6-tetrahidro-pirrolo[3,4-c]pirazol-3-il}-4-(4-metilpirazin-1-il)-benzamida; y uso de dicho compuesto y un vehicul
ECSP056216A (es) Tableta de liberación modificada del clorhidrato de bupropion